Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript

Agile Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.46 EPS, expectations were $-0.92.

Related Keywords

Matt Riley ,Al Altomari ,Agile Therapeutics Inc ,Nasdaq ,Agile Therapeutics ,Call Transcript March ,Agile Therapeutics Fourth Quarter ,Full Year ,Results Conference ,Investor Relations ,Agile Therapeutic Chair ,Chief Executive ,Insiders Are Dumping These ,Twirla January ,Affordable Care ,